This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., The Brigham and Women's Hospital, Inc., The Broad Institute, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,268 
3 out of 1,428 
3 out of 486 
Years Active: 2021-2024
Title: **Valeria Padovano: Innovator in Proteinopathies Treatment**
Introduction
Valeria Padovano, based in Cambridge, MA, has made significant strides in the realm of medical innovations. With a remarkable portfolio of three patents, her work primarily focuses on the diagnosis and treatment of various proteinopathies, showcasing her commitment to advancing healthcare through scientific ingenuity.
Latest Patents
Among Padovano's key contributions are her latest patents centered on "Agents for reversing toxic proteinopathies." These patents encompass compositions and methods aimed at diagnosing and treating conditions such as MUC1-associated kidney disease (ADTKD-MUC1 or MKD) and Retinitis Pigmentosa stemming from rhodopsin mutations. Her work also addresses autosomal dominant tubulo-interstitial kidney disease linked to UMOD mutations (ADTKD-UMOD) and various other toxic proteinopathies resulting from mutant protein accumulation in secretory pathway compartments. Additionally, she identifies TMED9-binding agents as potential treatments for these disorders, paving the way for novel therapeutic approaches.
Career Highlights
Valeria Padovano's career is marked by her contributions to prestigious research institutions, including the Broad Institute and Dana-Farber Cancer Institute. Her expertise in the field of proteinopathies has enabled her to explore innovative solutions that have significant implications for patients suffering from genetic and degenerative diseases.
Collaborations
Throughout her career, Padovano has collaborated with distinguished professionals such as Anna Greka and Moran Dvela-Levitt. These partnerships have fostered a dynamic research environment that encourages the exchange of ideas and the pursuit of groundbreaking solutions in the medical field.
Conclusion
Valeria Padovano exemplifies the spirit of innovation in the medical research landscape. With her dedication to understanding and treating proteinopathies, she stands at the forefront of scientific discovery, promising a brighter future for patients affected by these challenging conditions. Her patents not only illuminate her pioneering work but also highlight her potential to inspire future developments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile